Cite
HARVARD Citation
Meng, Z. et al. (2021). The efficacy of lorlatinib in a lung adenocarcinoma patient with a novel ALK G1202L mutation: a case report. Cancer biology & therapy. 22 (1), pp. 1-4. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Meng, Z. et al. (2021). The efficacy of lorlatinib in a lung adenocarcinoma patient with a novel ALK G1202L mutation: a case report. Cancer biology & therapy. 22 (1), pp. 1-4. [Online].